Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 25: The NEWTON-CABG CardioLink-5 Study
Author(s): Subodh Verma Added: 4 months ago
ESC Congress 2025 - NEWTON-CABG finds evolocumab with regular statin therapy did not improve vein graft patency after coronary artery bypass graft (CABG) surgery in the short-term.Dr Subodh Verma and Dr Lawrence Leiter (University of Toronto, Toronto, CA) join us to discuss findings from NEWTON-CABG CardioLink-5 (NCT03900026). The investigator-initiated multicenter, randomised, placebo-controlled… View more

Intervention
CRT 24: SYNTAX: PCI With TAXUS and CABG in Complex Coronary Disease
Author(s): Patrick W Serruys Added: 1 year ago
CRT 2024 — Prof Patrick W Serruys (National University of Ireland, Galway, US) joins us to discuss learning from the SYNTAX trial.The SYNTAX trial is a randomized controlled trial designed to evaluate the efficacy and safety of percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents versus coronary artery bypass grafting (CABG) in patients with complex coronary… View more

Intervention

Vascular Disease and Surgery
TCT 2025: 10-Year Mortality in NOBLE: PCI vs CABG for Left Main Disease
Author(s): Evald Høj Christiansen Added: 2 months ago
TCT 2025 - 10-year findings from NOBLE showed no safety concerns for percutaneous coronary intervention (PCI) compared to coronary artery bypass surgery (CABG) for the treatment of left main coronary artery (LMCA) disease.Dr Evald Høj Christiansen (Aarhus University Hospital, Aarhus, DK) joins us to share the 10-year mortality findings from the NOBLE trial, investigating PCI vs CABG in LMCA… View more

Intervention

Prevention & Chronic Conditions
AHA 24: The SELECT Trial
Author(s): Subodh Verma Added: 1 year ago
AHA Conference 2024 - Outcomes of SELECT show that semaglutide treatment in obese or overweight patients with prior history of coronary artery bypass graft (CABG) surgery reduces the risk of cardiovascular events.Dr Subodh Verma (University of Toronto, Toronto, CA) joins us onsite at AHA Conference to discuss the findings from SELECT (NCT03574597).SELECT is a randomized, double-blind, placebo… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Author(s): Rasha Al-Lamee , Michael Foley Added: 1 year ago
ACC.24 — Investigators, Dr Rasha K Al-Lamee and Dr Michael Foley (Imperial College London, UK) joined us to discuss the ORBITA COSMIC trial (NCT04892537).This randomized, double-blinded, placebo-controlled trial investigated the effects of coronary sinus reducer (CSR) as compared to placebo on myocardial perfusion via MRI, exercise duration, and symptoms in patients with refractory angina and… View more

Prevention & Chronic Conditions
Bruce Rollman
Job title: Professor of Medicine, Psychiatry, and Clinical and Translational Science
Dr Bruce L Rollman's research focuses on interventions to improve the quality of care for patients with depression and anxiety who are care for in non-psychiatric settings. Dr Rollman was also Principal Investigator for the Bypassing the Blues Trial that demonstrated the effectiveness and cost-effectiveness of a nurse-led and telephone-delivered collaborative care strategy for treating depression… View more
ESC 24 Hot Line Discussion: The SWEDEGRAFT Trial
Author(s): Harriette Van Spall , Stefan James Added: 1 year ago
ESC Congress 2024 — SWEDEGRAFT does not support the routine use of no-touch vein harvest compared to the standard technique.Dr Harriette Van Spall (McMaster University, CA) sits down with principal investigator Prof Stefan James (Uppsala University, SE) to discuss results of the SWEDEGRAFT trial (NCT03501303; Uppsala University).The SWEDEGRAFT trial is a prospective, binational, multicenter, open… View more

Intervention

Vascular Disease and Surgery
Kendra J Grubb
Research Area(s) / Expertise: Job title: Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine. Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease. Her… View more
ESC 24: The SENIOR RITA Trial
Author(s): Vijay Kunadian Added: 1 year ago
ESC Congress 2024 — No difference in cardiovascular outcomes between invasive and conservative strategies in elderly NSTEMI patients.Principal Investigator, Prof Vijay Kunadian (Newcastle upon Tyne Hospitals NHS Trust, UK) join us in London to discuss the key findings from the SENIOR RITA trial (NCT03052036; Newcastle-upon-Tyne Hospitals NHS Trust).The SENIOR-RITA trial is a multicenter, open… View more

Demographic

Prevention & Chronic Conditions
NVM Cardiology Meeting Reflections: What's Hot at TCT 25?
Author(s): Nicolas M Van Mieghem Added: 3 months ago
NVM Cardiology Conference Reflections: What’s Hot at TCT 2025?Join Prof Nicolas Van Mieghem, Transcatheter Interventions Online Course Director, as he shares his critical perspective on some of the key late-breaking data highlights from TCT 2025.What should we expect from the new data? Where should we take a closer look at the existing evidence and the premise of these trials? And which results… View more

Intervention